[Medroxyprogesterone acetate in urinary retention caused by inoperable prostatic hypertrophy].
D000368:Aged; D001161:Arteriosclerosis / Q000150:complications; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D014555:Urination Disorders / Q000209:etiology*
D008525:Medroxyprogesterone
Il medrossiprogesterone acetato nella ritenzione vescicale da ipertrofia prostatica inoperabile.